For more information about EFFEXOR XR, you can continue to the site here.
See full Prescribing Information, including boxed warning, and Medication Guide for patients.
Important Safety Information
Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, teens, and young adults. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. EFFEXOR XR® (venlafaxine HCl) is not approved for use in children and teens.
PRISTIQ, introduced in 2008, is another product from Wyeth approved by the FDA for the treatment of major depressive disorder in adults. Find out more.
PRISTIQ® (desvenlafaxine) is approved for the treatment of major depressive disorder in adults.
Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, teens, and young adults. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. PRISTIQ is not approved for use in children under 18.
Effexor XR® (venlafaxine HCI) is a prescription medication approved for the treatment of major depressive disorder (MDD), generalized anxiety disorder (GAD), social anxiety disorder (SAD), and panic disorder (PD) in adult patients.
Please see the Prescribing Information and Medication Guide for Effexor XR using the links below:
These documents are in PDF (Portable Document Format). PDF files require Adobe® Reader®; click here to download this free program.
Your guide has 0 topics.
No topics to add
See your guide
Close
Fill in the information below to send an e-mail message and a link to this page.
Recipient's e-mail address
Your e-mail address
Send
This form does not collect your information. To learn more about our use of your information and your rights, please consult our Privacy Policy.
A message has been sent to your intended recipient with a link to this page. He or she will receive it shortly.
Thank you.